A federal judge on Friday dismissed Amgen’s lawsuit against Colorado’s drug affordability board and its call for a price cap on the company’s blockbuster autoimmune drug. District Judge Nina Wang didn’t rule on the merits …
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
